High-density lipoprotein subpopulations in pathologic conditions.
Asztalos BF, Schaefer EJ.
Am J Cardiol. 2003 Apr 3;91(7A):12E-17E. doi: 10.1016/s0002-9149(02)03383-0.
PMID:12679198
High-density lipoprotein mimetics: promises and challenges.
Sviridov D, Remaley AT.
Biochem J. 2015 Dec 15;472(3):249-59. doi: 10.1042/BJ20150832.
PMID:26613945
High-Density Lipoprotein Therapy in Stroke: Evaluation of Endothelial SR-BI-Dependent Neuroprotective Effects.
Tran-Dinh A, Levoye A, Couret D, Galle-Treger L, Moreau M, Delbosc S, Hoteit C, Montravers P, Amarenco P, Huby T, Meilhac O.
Int J Mol Sci. 2020 Dec 24;22(1):106. doi: 10.3390/ijms22010106.
PMID:33374266
High-density lipoprotein and inflammation in cardiovascular disease.
Connelly MA, Shalaurova I, Otvos JD.
Transl Res. 2016 Jul;173:7-18. doi: 10.1016/j.trsl.2016.01.006. Epub 2016 Jan 20.
PMID:26850902
Genetic high density lipoprotein deficiency states and atherosclerosis.
Schaefer EJ, McNamara JR, Mitri CJ, Ordovas JM.
Adv Exp Med Biol. 1986;201:1-15. doi: 10.1007/978-1-4684-1262-8_1.
PMID:3099550
Two Cases of Acquired High-Density Lipoprotein Deficiency with Immunoglobulin G4-Related Lecithin-Cholesterol Acyltransferase Autoantibody.
Komatsu T, Katsurada Y, Miyashita K, Abe S, Nishida T, Endo Y, Teramoto M, Sasaki K, Arakawa J, Sasaki M, Suzuki N, Kuwata K, Imakiire T, Miyake T, Sakurada M, Matsukuma S, Hirano T, Uehara Y, Ikewaki K.
J Atheroscler Thromb. 2023 Aug 1;30(8):1070-1082. doi: 10.5551/jat.63616. Epub 2022 Nov 16.